Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 73 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

9 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

31 recruiting

Enrollment Performance

Analytics

N/A
28(56.0%)
Phase 2
12(24.0%)
Phase 3
7(14.0%)
Phase 4
2(4.0%)
Early Phase 1
1(2.0%)
50Total
N/A(28)
Phase 2(12)
Phase 3(7)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials
NCT04513418Phase 3Active Not Recruiting

Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

Role: collaborator

NCT07616518Not Yet Recruiting

Dynamic Trajectories of Pupillary Light Reflex Parameters and Prognosis in Critically Ill Patients: A Multicenter Prospective Cohort Study

Role: collaborator

NCT07604350Phase 3Not Yet Recruiting

Edaravone Dexborneol for Post-Stroke Epilepsy

Role: collaborator

NCT07572708Not ApplicableNot Yet Recruiting

Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Role: lead

NCT07553767Early Phase 1Not Yet Recruiting

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Role: collaborator

NCT07548281Not ApplicableNot Yet Recruiting

Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

Role: collaborator

NCT07542002Phase 2Recruiting

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study

Role: lead

NCT05738642Not ApplicableCompleted

Efficacy and Safety of Early Use PCC in Severe Trauma

Role: collaborator

NCT04866667Completed

Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT06850103Phase 2Recruiting

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT07451158Not ApplicableActive Not Recruiting

Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07177586Not ApplicableRecruiting

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

Role: collaborator

NCT07385131Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Role: collaborator

NCT07368023Not Yet Recruiting

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

Role: lead

NCT07347977Not ApplicableNot Yet Recruiting

Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk

Role: collaborator